![]() |
Name |
Emestrin
|
Molecular Formula | C27H22N2O10S2 | |
IUPAC Name* |
(1R,3S,9S,23S,24R,32R)-19,23,32-trihydroxy-15-methoxy-28-methyl-6,10,17-trioxa-25,26-dithia-2,28-diazaheptacyclo[22.2.2.11,4.12,24.112,16.118,22.03,9]dotriaconta-4,7,12(31),13,15,18,20,22(30)-octaene-11,27,29-trione
|
|
SMILES |
CN1C(=O)[C@]23[C@@H](C4=COC=C[C@H]5[C@H]4N2C(=O)[C@@]1([C@H](C6=CC(=C(C=C6)O)OC7=C(C=CC(=C7)C(=O)O5)OC)O)SS3)O
|
|
InChI |
InChI=1S/C27H22N2O10S2/c1-28-24(34)27-22(32)14-11-37-8-7-17-20(14)29(27)25(35)26(28,40-41-27)21(31)12-3-5-15(30)18(9-12)38-19-10-13(23(33)39-17)4-6-16(19)36-2/h3-11,17,20-22,30-32H,1-2H3/t17-,20-,21-,22+,26+,27+/m0/s1
|
|
InChIKey |
UWWYWUMDYAWTKK-YITDFDIYSA-N
|
|
Synonyms |
Emestrin; SCHEMBL1096344; (1R,3S,9S,23S,24R,32R)-19,23,32-trihydroxy-15-methoxy-28-methyl-6,10,17-trioxa-25,26-dithia-2,28-diazaheptacyclo[22.2.2.11,4.12,24.112,16.118,22.03,9]dotriaconta-4,7,12(31),13,15,18,20,22(30)-octaene-11,27,29-trione
|
|
CAS | NA | |
PubChem CID | 11758256 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 598.6 | ALogp: | -0.1 |
HBD: | 3 | HBA: | 12 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 206.0 | Aromatic Rings: | 8 |
Heavy Atoms: | 41 | QED Weighted: | 0.326 |
Caco-2 Permeability: | -5.438 | MDCK Permeability: | 0.00001920 |
Pgp-inhibitor: | 0.056 | Pgp-substrate: | 0.037 |
Human Intestinal Absorption (HIA): | 0.806 | 20% Bioavailability (F20%): | 0.996 |
30% Bioavailability (F30%): | 0.997 |
Blood-Brain-Barrier Penetration (BBB): | 0.113 | Plasma Protein Binding (PPB): | 59.49% |
Volume Distribution (VD): | 1.452 | Fu: | 26.92% |
CYP1A2-inhibitor: | 0.123 | CYP1A2-substrate: | 0.082 |
CYP2C19-inhibitor: | 0.903 | CYP2C19-substrate: | 0.443 |
CYP2C9-inhibitor: | 0.959 | CYP2C9-substrate: | 0.507 |
CYP2D6-inhibitor: | 0.759 | CYP2D6-substrate: | 0.134 |
CYP3A4-inhibitor: | 0.873 | CYP3A4-substrate: | 0.953 |
Clearance (CL): | 10.428 | Half-life (T1/2): | 0.482 |
hERG Blockers: | 0.102 | Human Hepatotoxicity (H-HT): | 0.072 |
Drug-inuced Liver Injury (DILI): | 0.987 | AMES Toxicity: | 0.04 |
Rat Oral Acute Toxicity: | 0.999 | Maximum Recommended Daily Dose: | 0.991 |
Skin Sensitization: | 0.586 | Carcinogencity: | 0.986 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
Respiratory Toxicity: | 0.92 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005392 | ![]() |
0.367 | D0AZ8C | ![]() |
0.323 | ||
ENC003545 | ![]() |
0.290 | D07MGA | ![]() |
0.266 | ||
ENC002358 | ![]() |
0.287 | D05HSC | ![]() |
0.259 | ||
ENC003176 | ![]() |
0.286 | D0L1JW | ![]() |
0.250 | ||
ENC003381 | ![]() |
0.285 | D06TJJ | ![]() |
0.247 | ||
ENC003540 | ![]() |
0.285 | D06GCK | ![]() |
0.243 | ||
ENC003992 | ![]() |
0.282 | D0I9HF | ![]() |
0.239 | ||
ENC005410 | ![]() |
0.282 | D05MQK | ![]() |
0.236 | ||
ENC003382 | ![]() |
0.281 | D0Q0PR | ![]() |
0.232 | ||
ENC004849 | ![]() |
0.281 | D01DBQ | ![]() |
0.229 |